Measles immunization: Early two-doses policy experience

Journal of Tropical Pediatrics

Volumn 45, Issue 2, 1999, Pages 98-104

  Al Mazrou, Yagob Y ^a   Al Jeffri, Mohamed ^a   Ahmed, Omer M M ^a   Aziz, Khwaja M S ^a   Mishkas, Amin H ^a  

^a MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; HUMAN; INCIDENCE; MEASLES; MEASLES VACCINATION; SAUDI ARABIA;

EID: 0032963359     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/45.2.98     Document Type: Article

References (32)

1. Division of Microbiology and Infectious Diseases, National Institutes of Health. The Jordan Report: Accelerated Development of Vaccines 1995. National Institutes of Health, Washington, DC, 1995; 1-82.
2. Ndikuyeze A, Cooka A, Cutts FT, Bennett S. Priorities in global measles control: report of an outbreak in N'Djamena, Chad. Epidemiol Infect 1995; 115: 309-14.
3. MMWR. Progress towards global measles control and elimination, 1990-1996. MMWR 1997; 46: 893-7.
4. Chiu HH, Lee CY, Chih TW, et al. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. J Med Virol 1997; 51: 32-5.
5. MMWR. Measles-United States, 1995. MMWR 1996; 45: 305-7.
6. Forest JM, Burgess MA. Update on immunization. Curr Opin Pediatr 1996; 8: 21-7.
7. MMWR. Measles prevention: recommendations of the immunization practices advisory committee (ACIP). MMWR 1989; 38: 1-18.
8. Hutchins S, Markowitz L, Atkinson W, Swint E, Hadler S. Measles outbreaks in the United States, 1987 through 1990. Pediatr Infect Dis J 1996; 15: 31-8.
9. Kyucu N, Dogru U, Akar N. Antibody response to measles vaccination in Turkish children. Infection 1996; 24: 156-9.
10. Nokes DJ, Williams JR, Butler AR. Towards eradication of measles virus: global progress and strategy evaluation. Vet Microbiol 1995; 44: 333-50.
11. Liu CC, Lei HY, Chiang YP. Seroepidemiology of measles in southern Taiwan; two years after implementation of the measles elimination program. J Formos Med Assoc 1996; 95: 37-40.
12. Watson WJ, Pearson JA, Markowitz LE, et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics 1996; 97: 613-18.
13. Ikic, DM, et al. Edmonston Zagreb vaccine further attenuated in HOC. In: Gusci B (ed.), Proceedings of the Symposium on Human Diploid Cells. Yugoslavia Academy of Science and Arts, Zagreb 1970; 113-20.
14. Garenne M, et al. Child mortality after high-litre measles vaccines: prospective study in Senegal. Lancet 1991; 338: 903-7.
15. Ministry of Health. Measles below the age of one year - unpublished report. Ministry of Health, Saudi Arabia, 1989.
16. Whittle HC, Rowland MG, Mann GF, Lamb WH, Lewis RA. Immunization of 4-6 months old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet 1984; ii: 834-7.
17. Khanum S, Uddin N, Garelick H, Mann G, Tomkins A. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet 1987; i: 150-3.
18. Aaby P, Jensen TG, Hansen HL, et al. Trial of high dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet 1988; ii: 809-11.
19. Whittle H, Hanlon P, O'Neill K, et al. Trial of high dose Edminston-Zagreb measles vaccine in the Gambia: antibody response and side-effects. Lancet 1988; ii: 811-14.
20. Centres for Disease Control. Measles, United States, 1984. MMWR 1985; 21: 308-12.
21. Ministry of Health. Annual Health Report. Research and Planning Department, Riyadh, Saudi Arabia, 1995.
22. Expanded Program on Immunization (EPI). Immunization in the English Speaking Caribbean. Weekly Epidem Rec 1996; 29: 217-19.
23. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the Americas. Evolving strategies. J Am Med Assoc 1996; 275: 224-9.
24. Johnson H, Hillary IB, McQuoid G, Gilmer BA. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland. Vaccine 1995; 13: 533-7.
25. Kuno-sekae, Ozaki K, Kimura H. Two dose measles, mumps, rubella (MMR) vaccine. Acta Paediatr Jpn 1989; 31: 690-7.
26. Davidkin I, Valle M, Julkuren I. Persistance of anti-mumps virus antibodies after a two dose MMR vaccine. A nine year follow up. Vaccine 1995; 13: 1617-22.
27. Liu BY, Ferng ZX, Xu AQ. A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4-7-month-olds. Chung Hua, Liu Using Ping Hsueh Tsa Chih 1995; 16: 263-5.
28. De Serres G, Boulianne N, Ratram S, Corriveau A. Effectiveness of vaccination at 6-11 months of age during an outbreak of measles. Paediatrics 1996; 97: 232-5.
29. Brugha R, Ramsay M, Forsey T, Brown D. A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect 1996; 117: 519-24.
30. Burstrom B, Aaby P, Mutie DM. Measles in infants: a review of studies on incidence, vaccine efficacy and mortality in East Africa. East Afr Med J 1995; 72: 155-61.
31. MMWR. Measles eradication: recommendations from a meeting co-sponsored by the World Health Organization, Pan American Health Organization and CDC. MMWR 1997; 46: 1-20.
32. WHO. Resolution World Health Assembly No 45.17. WHO, Geneva, 1989.